Tyvalzi™ is designed to treat cerebral ischemic stroke and is a first-in-class drug developed by Pharmazz for potential global use
Bajaj Healthcare's Savli plant is primarily involved in manufacturing Active Pharmaceutical Ingredients (API)
Torrent Pharma's interest stems from its desire to acquire a company with metrics more than 2.3 times its revenue, double its profit, and 1.46 times its market value
Tobramycin Ophthalmic Solution is used for the treatment of bacterial infections of the eye.
Aurobindo Pharma announced the product's launch in September 2023
The product will be available from September 2023 onwards.
In April-June 2023-24, the pharmaceutical company declared a net profit of Rs 520.5 crore.
It is a generic version of Hill Dermaceuticals Inc.'s Derma-Smoothe/FS 0.01% (Body Oil).
The company's consolidated profit after tax exhibited an 86 % sequential drop from Rs 26.55 crore.
The company plans to launch the product in August 2023.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund & Specialized Investment Fund Distributor), PFRDA Reg. No. PoP 20092018
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
